BDMD:NASDAQ, Baird Medical Investment Holdings Limited

Why BDMD stock rose on November 16

Baird Medical Investment Holdings Limited rose 17.7% on Monday, November 16, 2026, on 20,848,262 shares. No headline about BDMD came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

BDMD stock overview

Baird Medical Investment Holdings Limited (BDMD:NASDAQ) closed at $0.107 on November 16, 2026, up 17.68% on the day. The stock trades 97.1% below its 52-week high of $3.70 and 45.9% above its 52-week low of $0.073. Over the past year, it lost 92.1%. Baird Medical Investment Holdings Limited is part of the Health Care sector.

Key figures

Price
$0.107
Day change
+17.68%
Volume
20,848,262
Average volume
15,610,401
Market cap
3M+
52-week range
$0.073 – $3.70
50-day average
$0.606
200-day average
$1.29

Price action over the past year

In 252 trading sessions since November 14, 2025, BDMD closed higher on 93 days (37%). Its best day was February 17, 2026 (+63.64%) and its worst was November 6, 2026 (-44.30%). The stock moved 10% or more in a single session 31 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

BDMD news

About Baird Medical Investment Holdings Limited

Established in 2012 and headquartered in Guangzhou, China, Baird Medical is a leading microwave ablation ("MWA") medical device manufacturer and provider in China (and a recent entrant to the United States market). Baird Medical's proprietary medical devices are used for the treatment of benign and malignant tumors including thyroid nodules, liver cancer, lung cancer and breast lumps. Baird Medical is the first company to obtain a Class III medical devices registration certificate for MWA medical devices specifically indicated for thyroid nodules in China.

Similar stocks

Find more stocks like BDMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.